Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays
FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering…
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays
FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering…
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays
FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering…
Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases
HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company,…
Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases
HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company,…
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
New data showed a correlation between the levels of neural cell adhesion…
